دورية أكاديمية
Lipid and hemolysis parameters predicting acute chest syndrome in adulthood with sickle cell disease.
العنوان: | Lipid and hemolysis parameters predicting acute chest syndrome in adulthood with sickle cell disease. |
---|---|
المؤلفون: | Feugray G; Department of General Biochemistry, Normandie Univ, UNIROUEN, INSERM U1096 EnVI, CHU Rouen, Rouen, F-76000, France. guillaume.feugray@chu-rouen.fr.; Service de Biochimie, Centre hospitalier Universitaire Charles Nicolle, 1 rue de Germont, Rouen, 76031, France. guillaume.feugray@chu-rouen.fr., Grall M; Department of Internal Medicine, CHU Rouen, Rouen, F-76000, France., Dumesnil C; Department of Pediatric Onco-Hematology, CHU Rouen, Rouen, F-76000, France., Brunel V; Department of General Biochemistry, CHU Rouen, Rouen, F-76000, France., Benhamou Y; Department of Internal Medicine, Normandie Univ, UNIROUEN, INSERM U1096, CHU Rouen, Rouen, F-76000, France., Quillard Muraine M; Department of General Biochemistry, Normandie Univ, UNIROUEN, INSERM U1404 INSERMU1073 ADEN, CHU Rouen, CIC-CRB, Rouen, F-76000, France., Billoir P; Normandie Univ, UNIROUEN, INSERM U1096 EnVI, CHU Rouen, Vascular Hemostasis Unit, Rouen, F-76000, France. |
المصدر: | Lipids in health and disease [Lipids Health Dis] 2024 May 16; Vol. 23 (1), pp. 140. Date of Electronic Publication: 2024 May 16. |
نوع المنشور: | Journal Article |
اللغة: | English |
بيانات الدورية: | Publisher: BioMed Central Country of Publication: England NLM ID: 101147696 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-511X (Electronic) Linking ISSN: 1476511X NLM ISO Abbreviation: Lipids Health Dis Subsets: MEDLINE |
أسماء مطبوعة: | Original Publication: [London] : BioMed Central, 2002- |
مواضيع طبية MeSH: | Anemia, Sickle Cell*/blood , Anemia, Sickle Cell*/complications , Acute Chest Syndrome*/blood , Acute Chest Syndrome*/etiology , Hemolysis*, Humans ; Male ; Female ; Adult ; Cholesterol, LDL/blood ; Middle Aged ; Triglycerides/blood ; Cholesterol, HDL/blood ; Bilirubin/blood ; Lipids/blood |
مستخلص: | Sickle cell disease (SCD) is a lifelong blood disorder affecting approximately 100,000 people in the United States and is one of the most common monogenic diseases. A serious complication of SCD is acute chest syndrome (ACS). ACS is a condition with a high rate of morbidity and mortality. The aim of the study was to assess hemolysis and lipid parameters in a cohort of confirmed SCD patients to predict ACS development in the following year.Standard lipid were performed (triglycerides, total cholesterol, high-density cholesterol, low-density cholesterol) panel to calculate of non-HDL-C, large buoyant LDL cholesterol (lbLDL-C) and small dense LDL cholesterol (sdLDL-C) with Sampson equation. Hemolysis and hematologic parameters were also evaluated.Among 91 patients included between September 2018 and June 2021, thirty-seven patients had history of ACS and 6 patients developed ACS during following year. In unadjusted logistic regression, total bilirubin was associated with ACS occurrence (RR: 1.2 [1.05-1.51] p = 0.013). Concerning lipid profile, non-HDL-C (RR: 0.87 [0.0.67-0.99] p = 0.04) and sdLDL-C (RR: 0.78 [0.49-0.96] p = 0.03) were associated with ACS occurrence decrease. C-reactive protein was associated with ACS occurrence (RR: 1.27 [1.065-1.85] p = 0.011).Based on these findings, this study demonstrated that several biomarker easily available can be used at steady state to predict ACS in the following year. The validation of these results are required to ensure the reproducibility of the findings. (© 2024. The Author(s).) |
References: | Lipids. 2013 Dec;48(12):1217-26. (PMID: 24113910) Eur J Haematol. 2011 Sep;87(3):191-207. (PMID: 21615795) Front Endocrinol (Lausanne). 2022 Jun 20;13:877794. (PMID: 35795149) N Engl J Med. 2017 Apr 20;376(16):1561-1573. (PMID: 28423290) Br J Haematol. 2012 Jun;157(5):627-36. (PMID: 22463614) Sci Rep. 2023 Dec 1;13(1):21198. (PMID: 38040880) Blood. 1994 Jul 15;84(2):643-9. (PMID: 7517723) Ann Hematol. 2020 May;99(5):947-953. (PMID: 32140892) Arch Physiol Biochem. 2020 May;126(2):166-171. (PMID: 30145922) Scand J Clin Lab Invest. 2019 Oct;79(6):381-387. (PMID: 31187639) N Engl J Med. 2000 Jun 22;342(25):1855-65. (PMID: 10861320) Clin Chem. 2021 Jul 6;67(7):987-997. (PMID: 33876239) Front Med (Lausanne). 2022 Apr 13;9:858911. (PMID: 35492334) Am J Hematol. 2023 Jul;98(7):E175-E178. (PMID: 37096490) Clin Biochem. 2012 Dec;45(18):1578-82. (PMID: 22892192) Haematologica. 2010 Sep;95(9):1467-72. (PMID: 20378559) Br J Haematol. 2010 May;149(3):436-45. (PMID: 20230401) Chest. 2016 Apr;149(4):1082-93. (PMID: 26836899) Front Cardiovasc Med. 2022 Oct 05;9:883812. (PMID: 36277754) Am J Hematol. 2016 Dec;91(12):1185-1190. (PMID: 27543812) Clin Chim Acta. 2006 Mar;365(1-2):217-20. (PMID: 16185676) Blood. 2000 Nov 1;96(9):3276-8. (PMID: 11050014) Chest. 2022 Jul;162(1):120-131. (PMID: 35167862) Lipids Health Dis. 2018 Mar 5;17(1):38. (PMID: 29506549) J Lipids. 2016;2016:7650530. (PMID: 28078142) J Biomech. 2017 Jan 4;50:34-41. (PMID: 27876368) Br J Haematol. 2012 Feb;156(4):433-45. (PMID: 22122125) Lipids Health Dis. 2019 Dec 20;18(1):225. (PMID: 31861992) Lipids Health Dis. 2017 Apr 11;16(1):74. (PMID: 28399852) Hematology Am Soc Hematol Educ Program. 2007;:68-73. (PMID: 18024611) Braz J Med Biol Res. 2019 Oct 14;52(10):e8833. (PMID: 31618296) Dis Markers. 2020 Aug 18;2020:8842362. (PMID: 32884585) Br J Haematol. 1975 Sep;31(1):87-94. (PMID: 1212438) EBioMedicine. 2016 Aug;10:305-11. (PMID: 27412264) Hematology. 2015 Jun;20(5):289-96. (PMID: 24801127) Am J Emerg Med. 2022 Aug;58:235-244. (PMID: 35717760) Membranes (Basel). 2022 Nov 11;12(11):. (PMID: 36422126) Metabolomics. 2022 Dec 2;18(12):101. (PMID: 36459297) JAMA Cardiol. 2020 May 1;5(5):540-548. (PMID: 32101259) Expert Rev Hematol. 2022 Jun;15(6):547-558. (PMID: 35666654) Am J Hematol. 2005 May;79(1):61-7. (PMID: 15849760) PLoS One. 2014 Apr 16;9(4):e94387. (PMID: 24740290) Lipids Health Dis. 2010 Aug 27;9:91. (PMID: 20799970) Arthritis Rheumatol. 2014 Sep;66(9):2613-20. (PMID: 24782338) Am J Hematol. 2014 Nov;89(11):E212-7. (PMID: 25088663) Adv Hematol. 2020 Mar 17;2020:9864371. (PMID: 32256600) J Clin Lipidol. 2018 Nov - Dec;12(6):1532-1538. (PMID: 30219641) Blood. 1997 Mar 1;89(5):1787-92. (PMID: 9057664) |
فهرسة مساهمة: | Keywords: Acute chest syndrome; Hemolysis; Inflammatory; Lipid parameters; Sickle cell disease |
تواريخ الأحداث: | Date Created: 20240516 Date Completed: 20240517 Latest Revision: 20240519 |
رمز التحديث: | 20240519 |
مُعرف محوري في PubMed: | PMC11100209 |
DOI: | 10.1186/s12944-024-02135-8 |
PMID: | 38755670 |
قاعدة البيانات: | MEDLINE |
تدمد: | 1476-511X |
---|---|
DOI: | 10.1186/s12944-024-02135-8 |